Conference
An updated analysis of JULIET, a global pivotal phase 2 trial of tisagenlecleucel in adult patients with relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL)
Authors
Borchmann P; Tam CS; Jaeger U; McGuirk JP; Holte H; Waller EK; Jaglowski SM; Bishop MR; Andreadis C; Foley SR
Volume
41
Pagination
pp. 36-37
Publisher
KARGER
Publication Date
January 1, 2018
Conference proceedings
ONCOLOGY RESEARCH AND TREATMENT
ISSN
2296-5270